Tag Archives: DEA

Telemedicine Prescribing and Controlled Substances Laws

Editor’s Note: This article is the first of a series addressing telemedicine prescribing and controlled substances, designed to give some much needed practical guidance and orientation to established health care providers, hospitals, and entrepreneurs alike. As providers become more comfortable with delivering care via telemedicine, telehealth, and digital health technologies, some are exploring services beyond … Continue reading this entry

Telemedicine Prescribers Should Read This Case: U.S. vs. Zadeh

Health care providers who use telemedicine for remote prescribing of controlled substances should pay close attention to an important case currently pending at the Fifth Circuit Court of Appeals. The case will decide whether or not the Drug Enforcement Administration can use administrative subpoenas to obtain and review medical records without a warrant to determine … Continue reading this entry